Abbott Laboratoriesvs.Natera
ABT vs NTRA · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 4.2× larger than Natera by market cap; year to date, Natera leads (+17.8% vs −25.0%).
Side by side
| ABT | NTRA | |
|---|---|---|
| Market cap | $164B | $38.8B |
| Price | $93.93 | $269.95 |
| Today | −0.5% | −4.2% |
| Return YTD | −25.0% | +17.8% |
| Return 1Y | −29.7% | +65.2% |
| P/E | 26.1 | — |
| P/S | 3.6 | 15.5 |
| P/B | 3.1 | 21.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
American healthcare group with four divisions: diagnostics, medical devices (including glucose monitoring), nutrition and generics.
Full ABT profile →NateraNTRA
Molecular and genetic diagnostics across prenatal screening, oncology and transplantation.
Full NTRA profile →More comparisons in Diagnostics
See where ABT and NTRA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →